BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18712980)

  • 1. Factors influencing in-hospital length of stay and mortality in cancer patients suffering from febrile neutropenia.
    Lal A; Bhurgri Y; Rizvi N; Virwani M; Memon RU; Saeed W; Sardar MR; Kumar P; Shaikh AJ; Adil S; Masood N; Khurshed M
    Asian Pac J Cancer Prev; 2008; 9(2):303-8. PubMed ID: 18712980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.
    Kuderer NM; Dale DC; Crawford J; Cosler LE; Lyman GH
    Cancer; 2006 May; 106(10):2258-66. PubMed ID: 16575919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital.
    Osmani AH; Ansari TZ; Masood N; Ahmed B
    Asian Pac J Cancer Prev; 2012; 13(6):2523-6. PubMed ID: 22938399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia.
    Dulisse B; Li X; Gayle JA; Barron RL; Ernst FR; Rothman KJ; Legg JC; Kaye JA
    J Med Econ; 2013; 16(6):720-35. PubMed ID: 23452298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality, length of stay, and cost associated with hospitalized adult cancer patients with febrile neutropenia.
    Chindaprasirt J; Wanitpongpun C; Limpawattana P; Thepsuthammarat K; Sripakdee W; Sookprasert A; Wirasorn K
    Asian Pac J Cancer Prev; 2013; 14(2):1115-9. PubMed ID: 23621197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of stay and mortality associated with febrile neutropenia among children with cancer.
    Basu SK; Fernandez ID; Fisher SG; Asselin BL; Lyman GH
    J Clin Oncol; 2005 Nov; 23(31):7958-66. PubMed ID: 16258096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
    Bradley AM; Deal AM; Buie LW; van Deventer H
    Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.
    Ramsey SD; Liu Z; Boer R; Sullivan SD; Malin J; Doan QV; Dubois RW; Lyman GH
    Value Health; 2009; 12(2):217-25. PubMed ID: 18673353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database].
    Freyer G; Scotte F; Borget I; Bruyas A; Vainchtock A; Chouaid C
    Bull Cancer; 2016 Jun; 103(6):552-60. PubMed ID: 27233367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy.
    Cosler LE; Sivasubramaniam V; Agboola O; Crawford J; Dale D; Lyman GH
    Value Health; 2005; 8(1):47-52. PubMed ID: 15841893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of direct medical costs of hospitalization for febrile neutropenia.
    Lathia N; Mittmann N; DeAngelis C; Knowles S; Cheung M; Piliotis E; Shear N; Walker S
    Cancer; 2010 Feb; 116(3):742-8. PubMed ID: 20029970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
    Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J
    Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy.
    Chia VM; Page JH; Rodriguez R; Yang SJ; Huynh J; Chao C
    Breast Cancer Res Treat; 2013 Apr; 138(2):621-31. PubMed ID: 23468242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies.
    Shayne M; Culakova E; Poniewierski MS; Dale DC; Crawford J; Wogu AF; Lyman GH
    J Geriatr Oncol; 2013 Oct; 4(4):310-8. PubMed ID: 24472473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
    Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
    Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center.
    Osmani AH; Jabbar AA; Gangwani MK; Hassan B
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2741-2745. PubMed ID: 29072402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre.
    Schelenz S; Giles D; Abdallah S
    Ann Oncol; 2012 Jul; 23(7):1889-93. PubMed ID: 22048152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.